Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:972 (3 May), doi:10.1136/bmj.39554.402199.BE
Legalising production for medical usage is neither feasible nor desirable
| The first 150 words of the full text of this article appear below. |
The case for allowing Afghanistan to cultivate poppies to combat the alleged shortage of opiate medicines has been reported in the BMJ.1 Around 90% of the worlds opium comes from Afghanistan, and most of it is destined for the illicit market. Counter narcotics is at the heart of the United Kingdoms involvement in Afghanistan, not just because it is a major source of finance for the Taliban, but also because of its impact on our streets and neighbourhoods. The UK has repeatedly considered legal poppy cultivation—the first time in a report by David Mansfield that was commissioned in 2001.2 The findings of the Mansfield report remain true today; unless the Afghan government can control the size of the crop, legal opium will supplement and not substitute illegal opium production.
The Afghan government lacks the necessary resources, institutional capacity, and control mechanisms to guarantee that opium is only purchased legally.
Mark Malloch-Brown, minister of state for Africa, Asia, and the UN
1 Foreign and Commonwealth Office, London SW1A 2AH
Stelios.Kyriakides@fco.gov.uk
Read all Rapid Responses